Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

CD4 count news

Show

From To
Baseline CD4 count biggest factor in long-term immune system improvements after starting HIV therapy

Pre-treatment CD4 cell count is the most important factor in immune recovery following the initiation of combination antiretroviral therapy (cART), according to the results of a large observational

Published
14 December 2017
By
Michael Carter
HIV-positive children in resource-limited settings can achieve good virological outcomes without routine viral load or CD4 cell count monitoring

HIV-positive children can achieve good virological outcomes without routine monitoring of CD4 cell count or viral load, investigators report in PLOS Medicine. The research was

Published
27 November 2017
By
Michael Carter
HIV diagnoses in the UK fell in gay men last year for the first time since the mid-1990s, Public Health England confirms

The 2016 HIV surveillance figures released by Public Health England (PHE) today reveal that what has already been reported for specific clinics and at conferences is true nationally:

Published
03 October 2017
By
Gus Cairns
Marathon training is safe for people with HIV

Marathon run training is safe for people with HIV, investigators from Germany report in BMC Infectious Diseases. Training also had a number of beneficial effects,

Published
21 September 2017
By
Michael Carter
Point-of-care CD4 counts improve linkage to HIV care in Kenya

Carrying out a point-of-care CD4 count immediately after a person was diagnosed with HIV by home-based testing doubled the rate of linkage to HIV care,

Published
06 June 2017
By
Keith Alcorn
Life expectancy now near-normal in people with CD4 counts over 350 a year after starting therapy

A large study of 88,504 people with HIV on antiretroviral therapy (ART), published in The Lancet HIV journal and reported widely in the news, has found substantial

Published
15 May 2017
By
Gus Cairns
People taking ART in the UK have an accurate understanding of their viral load

The vast majority of people taking antiretroviral therapy (ART) in the UK have an accurate knowledge of their current viral load (VL) level, investigators report

Published
16 January 2017
By
Michael Carter
Less frequent CD4 and viral load monitoring safe for people doing well on ART

The frequency of routine monitoring for people treated with antiretrovirals with viral suppression can be safely reduced from every three months, to every six months, investigators from

Published
13 June 2016
By
Michael Carter
UK maintains the largest HIV epidemic in western Europe

The annual surveillance report released recently by the European Centre for Disease Prevention and Control (ECDC) shows that the number and rate of new diagnoses of HIV

Published
15 December 2015
By
Gus Cairns
IAS 2015: While “game-changing,” START trial draws “line in the sand” and sets “time a’ ticking” to stop preventable illnesses and death, calls for action are accompanied by questions of impact of inequities, obstacles

Study also showed that most commonly used measure — CD4 count does not give accurate projection of illness risk.

Published
21 July 2015
From
Science Speaks

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.